← All companies
Bristol-Myers Squibb Company
BMY
Market cap$118.31 B
Rank#136
Filings1,000
The table below shows Bristol-Myers Squibb Company's balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $10.21B | $10.35B | $11.46B | $9.12B | $13.98B | $14.55B |
| Short-term investments | - | - | - | $130.00M | $2.99B | $1.28B |
| Receivables | $9.59B | $9.01B | $8.88B | $8.15B | $7.98B | $7.22B |
| Inventory | $2.69B | $2.56B | $2.66B | $2.34B | $2.10B | $2.07B |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.